Xiaowen Pang

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study

Jianyun Lu, B. Andriopoulos, Jiaming Sun, 2022, Aesthetic Plastic Surgery.

Dermal Elastic Tissue Diseases

Gang Wang, Wen‐yuan Zhu, Q. Ju, 2018 .

Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B

J. Lian, Chang-xing Huang, X. Bai, 2017, Virology Journal.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.

Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial

Hong-Fu Xie, Gang Wang, Hong-Zhong Jin, 2019, Archives of Dermatological Research.